These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25587619)

  • 1. Markers of endothelial dysfunction in patients with non-alcoholic fatty liver disease and coronary artery disease.
    Elsheikh E; Younoszai Z; Otgonsuren M; Hunt S; Raybuck B; Younossi ZM
    J Gastroenterol Hepatol; 2014; 29(7):1528-34. PubMed ID: 25587619
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study.
    Dallio M; Masarone M; Caprio GG; Di Sarno R; Tuccillo C; Sasso FC; Persico M; Loguercio C; Federico A
    J Gastrointestin Liver Dis; 2017 Sep; 26(3):261-268. PubMed ID: 28922438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-selectin, endocan, and some adhesion molecules in obese children and adolescents with non-alcoholic fatty liver disease.
    Ustyol A; Aycan Ustyol E; Gurdol F; Kokali F; Bekpınar S
    Scand J Clin Lab Invest; 2017 May; 77(3):205-209. PubMed ID: 28318371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2：.
    Idilman IS; Akata D; Hazirolan T; Doganay Erdogan B; Aytemir K; Karcaaltincaba M
    J Diabetes; 2015 Mar; 7(2):279-86. PubMed ID: 24893617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocan Levels and Endothelial Dysfunction in Patients With Sarcoidosis.
    Aciksari G; Kavas M; Atici A; Kul S; Erman H; Yilmaz Y; Demircioglu K; Yalcinkaya E; Kanbay A; Caliskan M
    Angiology; 2018 Nov; 69(10):878-883. PubMed ID: 29747515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of vascular phenotype in patients with coronary artery ectasia: The role of endothelial dysfunction.
    Antonopoulos AS; Siasos G; Oikonomou E; Mourouzis K; Mavroudeas SE; Papageorgiou N; Papaioannou S; Tsiamis E; Toutouzas K; Tousoulis D
    Int J Cardiol; 2016 Jul; 215():138-9. PubMed ID: 27111177
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension.
    Wang XS; Yang W; Luo T; Wang JM; Jing YY
    Genet Test Mol Biomarkers; 2015 Mar; 19(3):124-7. PubMed ID: 25588082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory response in patients with coronary artery ectasia and coronary artery disease.
    Iwańczyk S; Borger M; Kamiński M; Chmara E; Cieślewicz A; Tykarski A; Radziemski A; Krasiński Z; Lesiak M; Araszkiewicz A
    Kardiol Pol; 2019 Aug; 77(7-8):713-715. PubMed ID: 31066726
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigation of the relationship between non-alcoholic fatty liver disease and coronary artery disease.
    Topuz M; Dogan A; Celik A; Can C; Ozdogru I; Kemal Eryol N
    Clin Ter; 2014; 165(1):e46-51. PubMed ID: 24589960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing picture of atherosclerosis. New view puts focus on improving artery health, not just fighting blockages.
    Harv Heart Lett; 2009 Jan; 19(5):4-5. PubMed ID: 19575513
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating endothelial cells and von Willebrand factor as indices of endothelial damage/dysfunction in coronary artery disease: a comparison of central vs. peripheral levels and effects of coronary angioplasty.
    Boos CJ; Jaumdally RJ; MacFadyen RJ; Varma C; Lip GY
    J Thromb Haemost; 2007 Mar; 5(3):630-2. PubMed ID: 17155959
    [No Abstract]   [Full Text] [Related]  

  • 12. Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease.
    Pinarbaşi B; Demır K; Oflaz H; Ahishali E; Akyüz F; Elıtok A; Çımen AO; Gölcük E; Güllüoğlu M; İşsever H; Beşişik F; Kaymakoğlu S; Ökten A
    Turk J Gastroenterol; 2012; 23(6):720-6. PubMed ID: 23794311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Endocan Levels in Patients With Isolated Coronary Artery Ectasia.
    Turan T; Akyuz AR; Aykan AC; Kul S; Cirakoglu OF; Aslan AO; Gul I; Uçar U; Demir S; Celik S
    Angiology; 2016 Nov; 67(10):932-936. PubMed ID: 26980772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study.
    Kose M; Emet S; Akpinar TS; Kocaaga M; Cakmak R; Akarsu M; Yuruyen G; Arman Y; Tukek T
    Angiology; 2015 Sep; 66(8):727-31. PubMed ID: 25168956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Biomarkers for Evaluation of Endothelial Dysfunction.
    Leite AR; Borges-Canha M; Cardoso R; Neves JS; Castro-Ferreira R; Leite-Moreira A
    Angiology; 2020 May; 71(5):397-410. PubMed ID: 32077315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Human Endothelial Cell-Specific Molecule-1 Level and Its Association With Coronary Artery Disease in Patients With Hypertension.
    Xiong C; Zhao ZW; Chen ZY; Wu LZ; Luo YK; Hu FD; Lin CG; Chen LL
    J Investig Med; 2015 Oct; 63(7):867-70. PubMed ID: 26200037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic Fatty Liver Disease Is Associated With Coronary Artery Calcification Development: A Longitudinal Study.
    Park HE; Kwak MS; Kim D; Kim MK; Cha MJ; Choi SY
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3134-43. PubMed ID: 27253666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dyslipidemias and endothelial changes].
    Bertolami MC
    Arq Bras Cardiol; 1995 Sep; 65(3):267-72. PubMed ID: 8579516
    [No Abstract]   [Full Text] [Related]  

  • 19. Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome.
    Kanbay A; Ceylan E; Köseoğlu Hİ; Çalışkan M; Takir M; Tulu S; Telci Çaklılı O; Köstek O; Erek A; Afsar B
    Clin Respir J; 2018 Jan; 12(1):84-90. PubMed ID: 27116287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease is associated with coronary artery disease and subclinical atherosclerosis.
    Aronow WS
    Future Cardiol; 2016 Jul; 12(4):393-6. PubMed ID: 27291253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.